News - TopAbstracts in Pancreatic Cancer 10/21/2009

	Unregistered User Click here if this is not your Personal Edition
		Contact Us \| Free E-Mail Updates \| Journals \| Register a colleague

Pancreatic Cancer

EXPLORE :

Most Read News

All News

All Webcasts / CME

All Cases

Congress Resource Centre

All Medical Resources

My Personal Edition

Warning | Privacy

Recent news - Pancreatic Cancer

	Endoscopic Ultrasound-Fine Needle Aspiration Predicts 5-year Survival in Pancreatic Endocrine Tumours - (DGNews)
	Radiation Therapy Effective for Pancreatic Neuroendocrine Tumours - (DGNews)
	TopAbstracts in Pancreatic Cancer 11/18/2009 - (DGNews)
	Risk of pancreatic cancer in families with Lynch syndrome - (JAMA)

News archive

Recent webcasts/CME

Webcasts/CME archive

Recent cases - Pancreatic Cancer

	Xanthogranulomatous Inflammation of the Peripancreatic Region Mimicking Pancreatic Cystic Neoplasm
	Pancreatic Ampullary Carcinoma with Neck Metastases: A Case Report
	Small Pancreatic Cancer with Pancreas Divisum Preoperatively Diagnosed by Pancreatic Juice Cytology
	Pancreatic Carcinoma Associated with Portal Vein Tumor Thrombus: Three Case Reports
	Ectopic Pancreatic-Type Malignancy Presenting in a Meckel's Diverticulum: A Case Report and Review of the Literature

Cases archive

my personal edition > pancreatic cancer > news

E-Mail this item to a colleague

TopAbstracts in Pancreatic Cancer 10/21/2009

10/21/2009

TopAbstracts™ in Pancreatic Cancer are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guide™ newsletter or visited a website Powered by Doctor's Guide™ in the past 28 days. Over 2000 peer-reviewed journals are covered by TopAbstracts.

TopAbstracts - Past 28 days

Erlotinib 150 mg daily plus chemotherapy in advanced pancreatic cancer: an interim safety analysis of a multicenter, randomized, cross-over phase III trial of the 'Arbeitsgemeinschaft Internistische Onkologie' - (Anti-Cancer Drugs)
Gemcitabine plus irinotecan as first-line weekly therapy in locally advanced and/or metastatic pancreatic cancer - (Oncol Res)
Definitive chemoradiation therapy with capecitabine in locally advanced pancreatic cancer - (Anti-Cancer Drugs)
A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer - (Br J Cancer)
Novel agents for the treatment of adenocarcinoma of the pancreas - (Expert Rev Anticancer Ther)

TopAbstracts - Past 3 months

Phase II Study of Bevacizumab With Concurrent Capecitabine and Radiation Followed by Maintenance Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer: Radiation Therapy Oncology Group RTOG 0411 - (J Clin Oncol)
A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer - (Br J Cancer)
Second-line therapy for advanced pancreatic cancer: A review of the literature and future directions - (Cancer Treat Rev)
CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone - (Br J Cancer)
Radiofrequency ablation of solitary pancreatic insulinoma in a patient with episodes of severe hypoglycemia - (Eur J Gastroenterol Hepatol)

E-Mail this item to a colleague

To print, use this version